Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

84.12 +2.48 (+3.04%)
Streaming Delayed Price Updated: 3:37 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
News headline image
This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
 
Via Benzinga
News headline image
Ford Posts Downbeat Earnings, Joins MaxLinear, STMicroelectronics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials ↗
Viking Therapeutics stock is up on Thursday as VKTX investors react to the company preparing for a Phase 3 trial of its weight loss drug. 
Via InvestorPlace
News headline image
LINE Stock: 7 Things to Know as Lineage Starts Trading Today ↗
Lineage stock is going to start trading later today and we have all of the details investors need to know about LINE shares on Thursday. 
Via InvestorPlace
News headline image
Why Is Edwards Lifesciences (EW) Stock Down 22% Today? ↗
Edwards Lifesciences stock is down on Thursday as EW investors digest the company's latest earnings report and outlook this morning. 
Via InvestorPlace
News headline image
P/E Ratio Insights for Edwards Lifesciences ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today ↗
 
Via Benzinga
News headline image
The Analyst Landscape: 13 Takes On Edwards Lifesciences ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
News headline image
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House ↗
Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech... 
Via Benzinga
Topics Government Stocks
News headline image
Peering Into Edwards Lifesciences's Recent Short Interest ↗
 
Via Benzinga
News headline image
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today ↗
 
Via Benzinga
News headline image
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024 ↗
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year ↗
The company now expects full-year sales in its TAVR division to climb 5% to 7%. 
Via Investor's Business Daily
News headline image
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
What Analysts Are Saying About Edwards Lifesciences Stock ↗
 
Via Benzinga
News headline image
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday? ↗
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
News headline image
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move' ↗
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
News headline image
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally ↗
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
News headline image
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Acquire Innovalve
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades' ↗
UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591. 
Via Benzinga
News headline image
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review ↗
The Nasdaq and S&P 500 hit record highs, but small caps retreated. 
Via Investor's Business Daily
Topics Stocks
News headline image
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details ↗
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring... 
Via Benzinga
News headline image
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal ↗
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion. 
Via Investor's Business Daily
News headline image
Edwards Lifesciences to Sell Critical Care to BD
From Edwards Lifesciences Corporation
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.